text:
Your browser does not support iframes.
Bryan Coburn brought a sense of humor and enthusiasm to the stage that captivated the audience Tuesday at the Lancaster High School auditorium.
Coburn, the 2009 S.C. Teacher of the Year, was guest speaker during the Lancaster County School District's opening assembly for teachers.
Coburn told the crowd it's his dedication and toughness that really helps him be effective.
When Robyn Blackmon was a young child, she'd line up her teddy bears and dolls and teach them what she'd learned in school that day.
It was during those early years that the Great Falls native knew she wanted to be an educator.
Fast forward to 2009, and now she's being recognized for being one of the best in the profession in Lancaster County.
Blackmon, a kindergarten teacher at North Elementary School, is the year's Celebrate Great Teaching winner for the elementary level in the Lancaster County School District.
INDIAN LAND – Posters in Paula Adams' classroom feature a key phrase: "We all use math every day."
Adams, a math teacher at Indian Land High School, wants her students to know that math will be a large part of their daily lives, even if they don't pursue careers working closely with numbers.
One of her aims is to help prepare her students for the real world.
Dennis Dunham sat in the lounge area in Starr Hall reviewing his schedule, wondering what he's going to do with the dead time between his classes on Tuesdays and Thursdays.
Dunham, a sophomore at the University of South Carolina at Lancaster, is taking 14 hours this semester. Tuesdays and Thursdays will be inconvenient, as he has a nearly four-hour gap in between classes.
Cold sweats, shakes and restless nights were normal for Toren Volkmann. Total memory lapses were common in his life.
Alcohol controlled his life for years.
Volkmann, a Washington state native, started drinking in middle school and soon turned into an alcoholic. After years of binge drinking, sickness and a host of unfavorable consequences, he turned his life around.
Now he and his mother, Chris, travel the country telling their story of struggle, confusion, hope and perseverance.
Alexis Sanders is adjusting to life in the South, while Dr. Suzanne Penuel looks to become even more active in the local community.
Sanders and Penuel are the two newest full-time faculty members at the University of South Carolina at Lancaster. The Lancaster News caught up with both of them recently to see how things have been going so far this semester.
Alexis Sanders
INDIAN LAND – The fifth-annual Oratorical Expose, sponsored by the Lancaster District of the AME Zion Church, took place Sept. 24 at El Bethel AME Zion Church in Indian Land.
The event, held each fall, gives local teens a chance to sharpen their public-speaking skills.
Nearly 20 teens competed in this year's contest.
Each of the 25 churches in the district was asked to spearhead a training forum and pick a student to represent the church.
Josh Beckham, a second-year teacher at South Middle School, says the classroom is where he belongs.
Beckham worked for Founders Federal Credit Union as a sales representative after graduating college. Though the job allowed him to travel and meet people daily, he said he knew God was steering him in another direction.
So the Lancaster native started an alternative certification and began teaching history at South Middle last year. His first year went so well, the Lancaster County School District honored him in a big way.
INDIAN LAND – A person is on the ground dead, and it's your job to figure out how long the body has been there and what lead to the death.
What are all the parts of the digestive system and what should you be aware of when treating a diabetic patient?
The answers to those inquiries and more are being unraveled this semester in Jill Haun's classroom at Indian Land High School.
A local educator has been recognized with a national award for bringing innovative ideas to the classroom.
Hope Figuero, a fourth-grade teacher at Erwin Elementary School, is one of 100 winners of the 2009 Unsung Heroes award program sponsored by financial institution ING.
ING recognized those teachers for developing innovative programs and incorporating them into lessons.
Figuero, who also received a $2,000 grant, was presented her award earlier this month.
Copyright © 2018
The Lancaster News is your source for local news, sports, events, and information in Lancaster County and Lancaster, South Carolina, and the surrounding area..


text:
Treating osteoarthritis in geriatric dogs
Editor's Note: Ronald McLaughlin, DVM, DVSc, Dipl. ACVS, is a professor and chief of Small Animal Surgery at the College of Veterinary Medicine, Mississippi State University. He also is chief of staff at Mississippi State University's Animal Health Center and head of the Department of Clinical Sciences.
DVM: Do you see patients in a clinical setting, or do you devote your time to research and teaching only?
McLaughlin: Most of my research in this area has been on the management of osteoarthritis, not necessarily in geriatric patients, but in all ages. We've done clinical evaluations of new and existing nonsteroidal anti-inflammatory drugs (NSAIDs), nutraceuticals and other agents. We look to see if certain agents or newer drugs are more effective than what currently is being offered, if patients are more comfortable and whether these drugs should be part of the overall treatment for patients.
There's increasing evidence—in fact, a substantial body of knowledge now—that NSAIDs and nutraceuticals do help control inflammation and reduce the signs of osteoarthritis and, as such, are valuable treatments. However, there are still questions to be answered about which treatments are best and what new treatments might help improve patients' quality of life.
DVM: For veterinarians in clinical practice, what would you recommend as the most effective ways for them to relieve the signs of this condition in older canines?
McLaughlin: The ideal approach is a multimodal one. One treatment alone is unlikely to be fully effective. Rather, a combination of treatments helps make patients more comfortable and relieves signs. A good multimodal approach would entail NSAIDs for anti-inflammatory properties; analgesics for pain; nutraceuticals for comfort and to preserve cartilage; proper nutrition, for example, an omega-3-based diet; weight control or weight loss and physical therapy.
DVM: Are certain breeds most at risk?
McLaughlin: We see osteoarthritis in all breeds of both dogs and cats. That said, we do tend to see older, large-breed, athletic and working dogs with this condition. For the latter two, it may be that their signs are more obvious because the osteoarthritis affects their work.
DVM: What medications would you recommend? Any common contraindications or side effects veterinarians should watch for?
McLaughlin: Long-term use of NSAIDS can cause renal and gastrointestinal problems, especially in geriatric dogs. Veterinarians should watch for clinical signs of those complications and regularly get blood work done on such dogs. Also, veterinarians should never give an animal two NSAIDs at the same time.
A multimodal approach as I described earlier can enable veterinarians to lower the dosage or reduce the frequency of NSAID treatments, which is especially important in dogs that must be on NSAIDs for a long time.
DVM: Other than medications, what treatments, if any, have demonstrated relief in dogs? For example, physical and exercise therapy, massage, acupuncture or any other alternative medicine treatments?
McLaughlin: A lot of work has been done in alternative therapies to see if they reduce osteoarthritis signs. For example, physical therapy is becoming more common in veterinary medicine. With the right protocols and physical therapy modalities, patients have improved.
There's also been recent research that looked at laser therapy, electrostimulation and therapeutic ultrasonography that have shown some benefits, but more work is needed in these areas. The body of knowledge around nutraceuticals certainly has increased and does show some positive effects, though some seem more effective than others, based on the research.

subset: commoncrawl


text:
From The Associated Press:
Florida Gov. Rick Scott is asking a panel of psychiatrists to determine whether a convicted murderer is insane.
Scott on Wednesday agreed to temporarily stay the pending execution of John Errol Ferguson in order to let doctors decide whether or not he understands the death penalty and why he is about to be executed.
The governor in an executive order called for the examination to take place on Oct. 1. Scott says if Ferguson is competent he will proceed with the already-scheduled execution on Oct. 16.
Sixty-four-year-old Ferguson was convicted of murdering six people execution-style in a drug-related crime. Ferguson was also convicted for the murders of two Hialeah teenagers.
Ferguson's attorneys say that he has long exhibited symptoms of schizophrenia and has been plagued by hallucinations and delusions.
Ferguson has been on death row for 34 years, far longer than the average stay of about 12 years. Defense attorneys are arguing before the Supreme Court that to execute Ferguson now, after more than three decades, would be cruel and unusual, a violation of the 8th Amendment of the Constitution. Ferguson also is described by his defense attorneys as an "untreated paranoid schizophrenic" who "hallucinates that snakes come out of his cell walls to torment him."
Oral arguments before the Supreme Court are scheduled for Thursday, October 4.
See our story on Ferguson's execution order and grisly crimes, here.


text:
Most small business owners understand that growth is seldom an option—it takes growth to build a long-term sustainable business.
In this webinar, Ty Kiisel of OnDeck will help you recognize opportunities for growth and the four things you'll need to have in place before you try to finance that growth.
You'll discover how to:
- Recognize growth opportunities
- Use easy-to-evaluate steps for determining if financing growth makes sense for your business
- Prepare your business before growth opportunities arise to make financing easier
- Evaluate your credit situation to determine where you'll have the best odds of success when applying for a loan
Download the webinar transcript.


text:
SEATTLE – One week made all the difference for the Sounders FC in the Western Conference Finals. While they stumbled in the first leg and fell behind 3-0 in the aggregate-goal series at The Home Depot Center last week, they grabbed the game by the scruff of the neck on Sunday night in the return leg at CenturyLink Field.
The Sounders created scoring chances from early in the match and kept the pressure on the Galaxy throughout the match, only letting LA control possession in short bursts.
In the end, though, the 3-0 deficit proved too difficult a mountain to climb for the Sounders. They fought back with two goals to pull within a goal at 3-2, but could not equalize and were put away by a penalty in the second half. They finished with a 2-1 win on the night, but a 4-2 loss in the series, ending their 2012 campaign one game away from the MLS Cup final.
"Obviously, the damage was done to us in game number one. I thought tonight we came out and played with good resolve, good energy," Sounders FC head coach Sigi Schmid said. "We're showing that we can win playoff games. We made progress this year, but we have to make sure that the energy with which we played tonight is the energy that we play with all the time."
The Sounders appeared to get on the board in the 11th minute, when they got the ball to the top of the box and Christian Tiffert fed a ball through to Eddie Johnson behind the Galaxy defense. Johnson blasted a shot past LA goalkeeper Josh Saunders, but the flag was up for offside and the goal was disallowed.
Just over a minute later, Johnson took a through ball from Zach Scott, held off Omar Gonzalez and put a left-footed shot past Saunders to give Seattle the 1-0 lead and hope in the series, trailing 3-1 on aggregate.
"We were in their face the whole night and created chances. We are a team you can't sit back on," Johnson said.
Most of the rest of the first half played out evenly and Seattle's only other good chance came on a header from Fredy Montero, but Saunders was able to cover it for the save.
They came out with similar intensity to start the second half, though, and in the 57th minute Tiffert sent a corner kick to the near post and Scott leaned in to get his head to it and knock it past Saunders for a 2-0 lead in the match, bringing the Sounders within one goal at 3-2 in the series.
"I thought Zach was pretty solid. I thought it was one of – if not his best game of the year," Schmid said.
The Sounders continued to put pressure on the Galaxy in search of the equalizer, but LA was able to add to their lead against the run of play when Robbie Keane got to the endline in the box up the left side and popped the ball off the hand of Adam Johansson to draw a penalty call.
Keane converted on the PK for his fifth goal of the postseason and the Galaxy's lead became a commanding 4-2 in the 68th minute.
Schmid made two quick substitutions after the goal, bringing on David Estrada and Mario Martinez while shifting to a 3-5-2 formation to press for another goal. They added another attacker when Mauro Rosales unexpectedly came on in the 81st minute after missing the previous two matches with a hamstring strain.
While they looked dangerous through the final 20 minutes, the Sounders were unable to pull any closer and their season ended with a 4-2 aggregate loss to the defending MLS Cup champions.
"I know each and every one of us can look ourselves in the mirror and know we gave our all. We wouldn't change anything about tonight. We controlled the game, put it on our terms," Johnson said. "It was painful today. When you put yourself in difficult positions against the defending champs, it's tough to get back."
The Galaxy will face the Houston Dynamo in a rematch of the 2011 MLS Cup final at the Home Depot Center on December 1.
Sounders FC – Eddie Johnson (Zach Scott) 12; Zach Scott (Christian Tiffert) 57.
LA Galaxy – Robbie Keane (PK) 68.
Sounders FC – Eddie Johnson (caution) 68; Osvaldo Alonso (caution) 75; Osvaldo Alonso (caution/ejection) 95+.
LA Galaxy – None.
Sounders FC – Michael Gspurning, Adam Johansson (Mario Martinez 74), Jeff Parke, Jhon Kennedy Hurtado, Zach Scott, Christian Tiffert, Osvaldo Alonso, Brad Evans, Steve Zakuani (Mauro Rosales 81), Fredy Montero (David Estrada 73), Eddie Johnson.
LA Galaxy – Josh Saunders, Sean Franklin, Omar Gonzalez, Tommy Meyer, Todd Dunivant, Mike Magee, David Beckham, Marcelo Sarvas, Christian Wilhelmsson (Juninho 62), Edson Buddle (Michael Stephens 84), Robbie Keane.
|Sounders FC
|Shots on Goal


text:
SUNRISE PHARMACEUTICALS is a part of a major pharmaceutical group with a wide global footprint. The company develops & markets a wide range of quality and affordable generic and branded drugs. As a progressive company, it integrates people, processes and potentials towards the betterment of human life.
SUNRISE PHARMACEUTICALS is well organized by our young & dynamic visionary Managing Director / Chairman Mr.Kunal Shah, with the support of well efficient professionals with several years of experience in professional capacities to add & effort to address the current vacuum in a largely disorganized sector.
Our manufacturing capability includes a wide range of therapeutic products covering segments like Antibiotics/Antibacterials, Anti-Inflammatory, Anti-Ulcerant, Anti-Allergic, Multivitamins & Food Supplements, Injectables, Liquids, Softgelatins.
Given our strong emphasis on product quality and services, Sunrise Pharmaceuticals has been able to launch products with enhanced release profiles to ensure better treatment compliance and dosage convenience.
We aim to be a leading pharmaceutical company recognized in India and abroad for introducing good quality products, which shall be affordable and very useful for the community. We also aspire to give the best value to our stake holders through our quality and consumer oriented services and innovative products.
Assisted by a highly experienced and qualified team of experts, we are meeting the accurately meeting the requirements of our valuable clientele. Regular training programs and seminars are organized by us to keep our personnel aware of the prevailing industrial developments as well as to enhance their knowledge related to the concerned domain.
The Quality and pricing of our company products are accepted and appreciated by professional Medical Practioners.The company is enriched with WHO, GMP and ISO 9001 and is ECA qualified.
Monopoly rights, Complete Promotional Material, Visual Aid, Leave Behind Card, Catch Covers, Order Books, M.R. Gab, Gift Articles, Prescription Pads, Visiting Cards and many more...


text:
Robin Wright apologizes for an earlier mix-up. Her reps had thought she was on the East Coast filming the second season of her highly admired series, "House of Cards." It turns out she was actually on the West Coast; so there was this EDT/PDT confusion about the interview time.
Figuring out Wright's career is can be a bit puzzling, too. Early on, she starred in two of the most beloved films of all time — "The Princess Bride" and "Forrest Gump." Since then, she has tried to avoid being typecast, carving out a solid body of work, but not in films with such a cultural impact.
Now Wright's performance in "House of Cards" has reminded audiences just what a captivating actress she is. In the Netflix series — which was just released on DVD and still is available on the streaming service — she plays Claire Underwood, part of a Washington, D.C., power couple. Comparisons to Lady Macbeth are often made to her character, the head of a nonprofit company trying to get clean water to impoverished countries. Despite her do-gooder status, Claire often ruthlessly supports her ambitious, manipulative husband, Democratic Majority Whip Francis Underwood, played by Kevin Spacey.
"I think part of me was, 'TV? Really?' " says Wright about being offered the role on "House of Cards." She has done some television, but not as a series regular since she began her career on a daytime soap. "House of Cards," though, is a different animal.
"It's not TV," she observes. "It's a 13-episode film. That's what it feels like."
Based on a 1990 British miniseries, "House of Cards" is from filmmaker David Fincher ("The Social Network," "The Girl With the Dragon Tattoo") and written by Beau Willimon ("Ides of March").
Wright describes Fincher, whom she worked for in "Dragon Tattoo," as a master of persuasion, but adds she was confident in the quality of the production with him, Spacey and Willimon on board. The new "revolutionary live streaming" format intrigued her, too. Netflix released all 13 episodes the same day, Feb. 1, allowing for the latest trend — binge viewing — and it immediately saw a surge in subscriptions.
Then there was the lure of working with Spacey, whom Wright shared a scene with in the 1998 film "Hurlyburly."
"We giggle like little kids at camp between takes," she says about their working relationship. But a key for the actress was the chance to develop Claire, making her a true partner with Francis.
"David assured me that I'd be part of the collaboration in building the character with Kevin and Beau," she says. "A lot of times in this business, we are sold a package of goods, but I got exactly what I was sold."
The fact that Netflix had agreed at the beginning to two seasons of "House of Cards" — 26 episodes — allowed the filmmakers and actors to think about the show in a longer arc.
"That was a lot of the fun," says Wright, "because we didn't have to answer all the questions immediately," noting that they were able to discover things about the characters along the way. In Claire's case, the actress was able to slowly "reveal the cracks in the human being under the template of Lady Macbeth."
The 47-year-old actress says she has fought against being typecast over the years.
"I get offered the heartfelt and understanding mother or wife — internal and ethereal, who is deeply saddened by things," she says, laughing. "So playing Claire is great. I get to branch out and have fun."
As for the understanding mother/wife type, she says, "I basically have to turn down about eight of those roles to get one good one like 'She's So Lovely' or 'White Oleander.' "
While admitting it's tough for women in Hollywood, she says most actors get stereotyped anyway, whether it's as a bad guy or neurotic. "I'm not whining," she says. "I'm just saying that statistically, that's a fact," which is why she is developing projects of her own.
She is a producer on Israeli director Ari Folman's trippy half-animated science-fiction film "The Congress," which premiered at the Cannes Film Festival in May and was recently picked up for U.S. distribution.
Wright plays a character called Robin Wright in the film, which is something of a commentary on Hollywood and celebrity. Though there are elements similar to her own life, it's not autobiographical, the actress notes. The plot involves the character being told by her agent (Harvey Keitel) that the only way to save her career is by having herself scanned by the studio's computers and signing over her life rights so they can make whatever kind of "Robin Wright movie" they want.
"Ari wanted to use me because I happen to be in two of the most iconic films of the top hundred films in America," says Wright, who will also be seen later this year in "A Most Wanted Man" with Philip Seymour Hoffman and Rachel McAdams. In that film, based on the John le Carre novel, she plays a CIA operative — not a mother or a wife.
And as far as revealing anything about season two of "House of Cards," which she will be shooting until November, she even sounds like a CIA agent.
"Absolutely not," she responds when asked.
@roblowman1 on Twitter


text:
The office of business development (OBD) is establishing a comprehensive research tools initiative called Agent Reagent. This initiative is led by David Silva and Ece Auffarth. The OBD has begun contacting researchers at Einstein to identify the inventory of research tools located on campus and to ascertain their commercial potential. The goal of this initiative is to license patentable or nonpatentable college-owned biological materials or methods developed here at Einstein to industry.
For the most part research tools are patented or unpatented biologic materials developed during the normal course of scientific research and are designed to fulfill unmet needs. Unmet needs may arise because existing tools may not be sufficiently effective for certain applications or because no such tool exists. These tools can also benefit the research of others. Some examples include:
Research tools are important because they facilitate the scientific process. For example, the additional use of a research tool may lead to results that validate the inventor's observations or allow other researchers to address previously unanswerable questions. In addition, with the decline of federal support for biomedical research it is becoming ever more important to conserve financial resources where possible. Distributing our research tools as broadly as possible allows other researchers to conduct their research without having to replicate our tools or, due to limited resources, to abandon promising lines of inquiry.
Sharing of research tools among biomedical researchers also allows medical research to advance more qyuckly and efficiently, which serves the public good by leading to the more rapid identification of new therapeutics and diagnostics. Industry may also use these research tools for its internal research or to distribute them to others, depending on the nature of the research tool. The revenue generated by this initiative is then distributed according to Einstein's patent policy (whether or not the tool is patented).
Any invention (including research tools and other patented or nonpatented biologics) developed with government funding is required by federal law and the college's Official Policy on Patents and Licensing Agreements to be disclosed to our office so we can report the invention to the government.
The National Institutes of Health (NIH) urge that such tools be made available to other academic researchers through NIH Sharing Plans and Material Transfer Agreements, as well as to industrial partners through licensing and other methods of commercialization. The sharing of research tools leads to the efficient advancement of science and serves the public interest in a manner consistent with the academic mission and role of scientists at Einstein.
Licensing these reagents to commercial partners is a way to fulfill Einstein's obligations to our grantors (particularly the NIH), to support Einstein's mission, to assist our faculty's research and to better reward our faculty inventors.
If the statements below are TRUE, you most likely have a research tool.
If you think you may have a research tool and have not spoken with David Silva or Ece Auffarth yet, let them know! Please fill out the Research Tools Disclosure Form and submit it to our office. If you have any questions regarding this project, please contact David Silva.
The office of biotechnology uses Material Transfer Agreements or licensing agreements as the vehicles to transfer research tools developed at Einstein to industry and other researchers. Depending on the research tool, it is often preferable for the office to license one tool to several industry partners, nonexclusively. This provides opportunities for broader dissemination and increased use of the tool. The office has used this model effectively in licensing research tools for many of our investigators.
Keep in mind, just as each research tool is unique, so is its commercial value. The value of a research tool varies based on its use, functionality, accessibility, reproducibility, robustness and areas of applicability, among other qualities.


text:
Message Board
Jimmy Fox Message Board
Talk about the novels, new and used books that Fox has written!
Author Fox's Book Reviews
Deadly Pedigree
Nick Herald, a professional genealogist working in New Orleans, is hired to search for Louisiana relatives of an elderly man, a Holocaust survivor. After finding the old man murdered, Nick realizes that this is no ordinary case of innocent genealogical curiosity. He uncovers a tangled tale of betrayal, bigotry, lust, and shame spanning two centuries of Louisiana's history, back to the Civil War and slavery days and beyond. Nick stumbles upon murderous my...
Jackpot Blood: A Nick Herald Genealogical Mystery
A small, struggling Louisiana Indian tribe receives federal recognition, but tribal unity unravels when someone--or something--begins murdering tribe members. Is the planned casino a factor? Nick Herald, genealogical sleuth, is hired by the tribe to help establish guidelines for enrollment. He lands in the middle of a free-for-all involving other Louisiana tribes, crooked politicians, a powerful local family, gambling syndicates, and drug runners. Finall...
Lineages and Lies
Murder has a family tree . . . especially in New Orleans! Nick Herald, professional genealogist and amateur sleuth, delves into the murder of a fellow genealogist, a curmudgeonly old friend with many enemies and perhaps too much knowledge. Who killed Woodrow Bluemantle in his posh French Quarter hotel room? Someone is willing to risk everything to hide damaging facts�the killer strikes again and again! What is the mystery at the heart of the lineage...


text:
U.S. stocks fell, after the Standard & Poor's 500 Index extended a record yesterday, after a Federal Reserve official said the central bank may slow the pace of stimulus as early as this summer amid disappointing economic reports.
Wal-Mart Stores Inc. lost 2.2% after the world's largest retailer forecast second-quarter profit that was less than analysts estimated as the slow U.S. economy and higher taxes put pressure on consumers. Cisco Systems Inc. surged 13% after reporting fiscal third-quarter profit that topped estimates. Tesla Motors Inc. jumped 10% as it plans to sell as much as $830 million in shares and debt.
The S&P 500 fell 0.4% to 1,651.82 at 3:36 p.m. in New York. The Dow Jones Industrial Average dropped 33.84 points, or 0.2%, to 15,241.85. Trading of S&P 500 stocks was 11% higher than the 30-day average at this time of day.
"Today's disappointing economic reports will set the tone," Chad Morganlander, a Florham Park, New Jersey-based fund manager at Stifel Nicolaus & Co., which oversees about $130 billion, said by phone. "The U.S. economy is still struggling with lackluster growth and the recovery is far from self-sustaining, so equity markets are looking for guidance from central banks for their liquidity high."
The U.S. bull market has entered its fifth year. The S&P 500 has surged 144% from a 12-year low in 2009, driven by better-than-estimated corporate earnings and three rounds of bond purchases from the Federal Reserve.
Bond Buying
Equities extended losses this afternoon as Fed Bank of San Francisco President John Williams said the central bank may begin slowing the pace of its $85 billion in monthly bond-buying amid signs the economy is gradually gaining strength.
"We could reduce somewhat the pace of our securities purchases, perhaps as early as this summer" and end the program late this year, Williams said today in the text of a speech in Portland, Oregon.
Fed Chairman Ben Bernanke has said he would continue unprecedented stimulus until the jobless rate falls to 6.5% or inflation rises above 2.5%.
Jobless claims jumped by 32,000 to 360,000 in the week ended May 11, the most since the end of March, Labor Department figures showed today. Another report showed the cost of living in the U.S. fell in April for a second month, the first back-to- back declines in inflation since late 2008.
Copyright 2014 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


text:
Last night my build started acting strange. about every other restart the idle temps would jump about 25c. I figured I had an air bubble break loose and after every trick in the book, I turned to the radiators as the possible cause.
I broke out my Snap on BK 5500 Visual Inspection device to have a look. So at the risk of ridicule, and various smart *** remarks
the BK5500 is designed for inspecting inside small spaces. It's probably the best investment tool-wise I think i have made.
Inside the rad tank, so far so good.
The whole inspection device is slightly smaller diameter than a No 2 pencil. The adjustable lighting source and full color high res camera is about 1/4"
Another look at the cooling channels
It has a 90 degree adapter, this shot is actually taken from the inside of the radiator looking out ( that's a light fixture on the ceiling)
Guess what the blue thing is? that is a inlet/outlet plug they package it with, and it blocks the flow rather well. I went back to the box it shipped in and I had the correct number of them, so it apparently got pushed in at the factory.
This thing gets extremely close and holds focus. I have found damaged pins, burned DIMMs, small cracks in PCB's etc. If you build systems, you might want to check it out.


text:
|Up a level
Asokan, P K (2011) Biology of Green Mussel. [Teaching Resource]
Asokan, P K and Laxmilatha, P and Surendranath, V G and Sivadasan, M P (2011) Site selection for Mussel Culture. [Teaching Resource]
Asokan, P K and Mohamed, K S (2011) Mussel farming methods. [Teaching Resource]
Chakraborty, Kajal and Vijayagopal, P and Asokan, P K and Vijayan, K K (2011) Green mussel (Perna viridis L.) as healthy food, and as a nutraceutical supplement. [Teaching Resource]
Jagadis, I (2011) Spawning, larval development and spat settlement in the Venus clam Gafrarium tumidum (Roding, 1798) from south-east coast of India. Indian Journal of Fisheries, 58 (2). pp. 1-5.
Kaladharan, P and Asokan, P K (2011) Shellfish poisoning. [Teaching Resource]
Kaladharan, P and Tara, K (2011) Live algal feed and their culture. [Teaching Resource]
Kripa, V (2011) Environmental Impact Assessment of Suspended Bivalve culture. [Teaching Resource]
Kripa, V (2011) Social impact and women empowerment through mussel farming. [Teaching Resource]
Krishnakumar, P K (2011) Marine pollution monitoring using mussels. [Teaching Resource]
Laxmilatha, P and Rao, G Syda and Pattnaik, Phalguni and Rao, T Nageswara and Rao, M Prasada and Dash, Biswajit (2011) Potential for the hatchery production of spat of the green mussel Perna viridis Linnaeus (1758). Aquaculture, 312. pp. 88-94.
Libini, C L and Abraham, K J and Shanmugam, K and Rao, K Prakash and Kripa, V and Velayudhan, T S and Mohamed, K S (2011) Biometric relationships of the black winged pearl oyster, Pteria penguin (Roding, 1798) from Andaman and Nicobar Islands. Indian Journal of Fisheries, 58 (3). pp. 139-143.
Mohamed, K S (2011) Depuration of Mussels. [Teaching Resource]
Mohamed, K S (2011) Economics of Mussel culture. [Teaching Resource]
Mohamed, K S and Kripa, V and Radhakrishnan, P and Alloycious, P S and Leena, Ravi and Koya, K P Said and Appukuttan, K K (2011) Mabe Pearls : A simple way to value added pearls (Pamphlet). Central Marine Fisheries Research Institute, Cochin, Cochin.
Mohamed, K S and Kripa, V and Velayudhan, T S and Joseph, Mathew and Jenni, B and Alloycious, P S and Sharma, Rama and Durgekar, N Raveendra (2011) Oyster depuration display unit for high-end restaurants. NAIP Component 2 Project; A value chain on High Vlaue Shellfishes from mariculture systems. p. 19.
Mohamed, K S and Sasikumar, Geetha and Koya, K P Said and Venkatesan, V and Kripa, V and Durgekar, N Raveendra and Joseph, Mathew and Alloycious, P S and Mani, R and Vijay, D (2011) Know... The Master of the Arabian Sea - Purple-Back Flying Squid Sthenoteuthis oualaniensis. NAIP Booklet. Project Report. CMFRI, COCHIN, Cochin.
Mohamed, K S and Zacharia, P U (2011) EBFM - can it manage and conserve tropical Asian fish stocks? INFOFISH International, 2. pp. 50-54.
Sanil, N K and Vijayan, K K (2011) Diseases and Parasites of Bivalves. [Teaching Resource]
Sasikumar, Geetha and Krishnakumar, P K (2011) Aquaculture planning for suspended bivalve farming systems: The integration of physiological response of green mussel with environmental variability in site selection. Ecological Indicators, 11. pp. 734-740.
Sasikumar, Geetha and Krishnamoorthy, M and Krishnakumar, P K and Bhat, G S (2011) Accumulation of trace metals in green mussel Perna viridis in the shellfish harvesting environment along southern Karnataka coast. Indian Journal of Fisheries, 58 (1). pp. 53-58.
Suja, N and Mohamed, K S (2011) Role of co-operative societies in black clam fishery and trade in Vembanad Lake. Marine Fisheries Information Service (207). pp. 6-8.
Sundaram, Sujit and Deshmukh, V D (2011) Commercially exploited edible bivalves off Mumbai. Fishing Chimes, 31 (5). pp. 23-24.
Sundaram, Sujit and Deshmukh, V D (2011) Emergence of squid jigging in India. Fishing Chimes, 30 (12). pp. 18-20.
Sundaram, Sujit and Khan, Mohammad Zafar (2011) Biology of the spineless cuttlefish Sepiella inermis (Orbigny, 1848) from Mumbai waters. Indian Journal of Fisheries, 58 (2). pp. 7-13.
Thangavelu, R and Soundararajan, R and Poovannan, P (2011) Distribution and abundance of the mangrove bivalves Isognomon ephippium (Linnaeus) and Cyrena ceylonica (Chemnitz) in Andamans. Indian Journal of Fisheries, 58 (1). pp. 113-115.
Veena, S and Laxmilatha, P (2011) Clathrina clara (Calcarea: Clathrinida: Clathrinidae) as foulers on onshore farmed oysters (Pinctada fucata). Marine Biodiversity Records, 4 (e77). pp. 1-5.
Veena, S and Thomas, Sujitha and Raje, S G and Durgekar, N Raveendra (2011) Case of leucism in the spadenose shark, Scoliodon laticaudus (Müller and Henle, 1838) from Mangalore, Karnataka. Indian Journal of Fisheries, 58 (1). pp. 109-112.
Velayudhan, T S (2011) Mussel seed resources of India and seeding methods. [Teaching Resource]
Velayudhan, T S and Jenni, B and Joseph, Mathew and Alloycious, P S and Kripa, V and Mohamed, K S (2011) Integrated farming of mussel and edible oyster by self help groups in Sathar Island, Ernakulam District, Kerala. Marine Fisheries Information Service (207). pp. 21-23.
Velayudhan, T S and Menon, N R and Pillai, V K (2011) Study on the induced maturation of the Indian pearl oyster Pinctada fucata (Gould) at Tuticorin, Tamil Nadu, India. Indian Journal of Fisheries, 58 (2). pp. 23-27.
Venkatesan, V (2011) Recovery of a tagged sacred chank, Xancus pyrum var. acuta Hornell, 1916 (Gastropoda: Turbinellidae) after Six Years. Asian Fisheries Science, 24. pp. 96-99.
Zacharia, P U and Joshi, K K and Kanthan, K P (2011) First record of the pelagic stingray Pteroplatytrygon violacea (Boneparte, 1832) (Family: Dasyatidae) from the east coast of India. Indian Journal of Fisheries, 58 (1). pp. 95-98.


text:
Leading Dental Lab in Detroit MISK Dental Lab is a full-service dental laboratory serving America's dental community since 1980. As one of the top dental labs in the country, SK Dental offers the highest in quality dental restorations to dentists and patients all across the US. Our commitment to excellence and craftsmanship has helped to build the outstanding reputation we have. When it comes to choosing the best dental lab, you need a dedicated team that utilizes the latest industry technology and provides the attention to detail needed to create the highest quality products. Our full service dental laboratory located in Southfield, Michigan offers just that!
Why Choose SK Dental Lab?
- 100% of work is completed in-house
- Master dental technicians on staff
- 5-day turnaround on all digital impressions
- 35 years in business with decades of combined experience
We utilize the very best technology to produce top quality products that provide the best fit and function. To us, it's not just teeth - we're restoring smiles! That's why all our restoration work is done 100% in-house by our expert technicians. Our skilled technicians work closely with dentists and their patients to ensure that each restoration is a natural smile.
Dental Lab Services Near DetroitOur range of high quality products include:
- Crowns & Bridges - 5 Day Turnaround
- Porcelain Fused to Metal Restorations
- Full Cast Crown & Bridges
- Procera
- Captek
- Cosmetics
- SKNY Veneers
- IPS Empress
- Emax
- Bruxzir
- Orthodontics
- Plaster Study Model
- Bite Splints
- Mouthguards
- Retainers
- Fixed Appliances
- Anti-Snoring Appliances
- In-House CAD/CAM
- Zirconia Restorations
- CEREC In-Lab Milling
- Emax
- Prep Guide
- Dentures and Removables
- Cosmetic Denture
- Hi-Impact Denture
- Standard Choice Denture
- Suction Cup Denture
- Flexible Partial Denture
- Cast Metal Partial
- Same-Day Denture Repairs & Relines
- Implants
- Identification Services
- Treatment Planning
- Abutments
- Restoration of all implant systems
- Nobel Biocare
- Zimmer
- Dentsply
- Ankylos
- Straumann
- Thommen


text:
Updated: July 5, 2018169 Pages
What is Polycystic Kidney Disease?
According to the American Kidney Foundation, polycystic kidney disease (PKD) is the most common life threatening genetic disorder caused by a single gene and affects between 1 in 400 to 1,000 people worldwide. It is characterized by fluid-filled cysts that form in the nephrons of both kidneys (bilateral) and eventually lead to kidney failure in the majority of patients. Polycystic kidney disease is the fourth most common cause of kidney failure.
Cysts usually begin as an outpouching (like a blister) anywhere along the length of the nephrons. Approximately 70% of the cysts detach from the nephron when they are small and proceed to enlarge as they fill with either clear fluid or fluid that may contain blood cells. In patients with PKD, hundreds to thousands of cysts can develop that range from the size of a pinhead to as large as a grapefruit (10-20 cm.) in diameter. Each kidney may expand to as large as a football and may weigh up to 38 pounds. The continual enlargement of cysts crowds out healthy kidney tissue. The kidneys may quadruple in size before kidney function is affected at which point renal function rapidly declines.
In addition, normal tissue can be actively destroyed and fibrous tissue can form resulting in a condition called interstitial fibrosis. The combination of cysts and progressive interstitial fibrosis is thought to accelerate chronic renal failure, resulting in the kidney's loss of ability to cleanse the blood and concentrate urine.
There are at least three factors related to cyst formation in the kidney but exactly what triggers the process is unclear. These three factors include:
Hypertension (high blood pressure) is closely associated with PKD due to the increased burden placed on the blood vessels from inadequately filtered blood. It is often one of the earliest symptoms of PKD and develops in most patients by the age of 20 or 30.
Polycystic kidney disease (PKD) affects approximately 600,000-700,000 people in the United States. Approximately 12.5 million people worldwide are believed to suffer from PKD. It is also thought to account for 7-10% of people who are on dialysis and require mechanical filtration of blood.
Additional important facts about PKD include:
Knowledge is Critical when Dealing with a Life-Altering Condition such as Polycystic Kidney Disease
If you or a loved one has been diagnosed with PKD, it's critical to learn everything you possibly can about this condition so that you can make informed decisions about your treatment. That's why we created the Medifocus Guidebook on Polycystic Kidney Disease, a comprehensive 169 page patient Guidebook that contains vital information about PKD that you won't find anywhere in a single source.
The Medifocus Guidebook on Polycystic Kidney Disease starts out with a detailed overview of the condition and quickly imparts fundamentally important information about PKD, including:
A detailed overview of the major types of PKD which include:
The underlying causes of PKD including the role of genetic, cellular, and hormonal factors in the disease process.
The secondary complications that can develop as a consequence of PKD, including:
The predominant signs and symptoms of PKD.
Understanding the Standard Treatments... and the Treatment Options
The goals of treatment for patients with PKD include:
Understanding the standard treatments - and the treatment options - is critical for successfully achieving the goals of treatment for patients with PKD. As you read through the section of the Guidebook that focuses on the treatments for PKD, you will specifically learn about:
The treatment options that are available to manage specific symptoms and secondary complications of PKD, including:
The treatment options that are available for the management of patients with PKD who develop end-stage kidney disease, including:
The management of PKD during pregnancy.
A "One-of-a-Kind" Reference Guidebook on Polycystic Kidney Disease that Goes Way Beyond the Fundamentals
Since 1996, when Medifocus was founded, we've learned that many people with Polycystic Kidney Disease are seeking more specific information that goes beyond the fundamentals, such as the causes, diagnosis, standard treatments, and treatment options. That's why we developed a "one-of-a-kind" reference Guidebook that goes way beyond the basics and also includes the following sections:
A Guide to Recent Medical Literature on Polycystic Kidney Disease - This section of the Guidebook contains an extensive bibliography of over 100 references to recently published articles about Polycystic Kidney Disease in authoritative, peer-reviewed medical journals with links to the absracts (summaries) of the articles. These articles represent the latest advances in the field and focus on cutting-edge research, new developments, and the lessons learned from recently published clinical trials involving patients with Polycystic Kidney Disease. This is the same level of that is used by doctors who treat people with Polycystic Kidney Disease to keep abreast of the latest developments and breakthroughs in this specialized field of medicine.
Centers of Research for Polycystic Kidney Disease - We've compiled a unique directory of doctors, hospitals, medical centers, and research institutions with special interest and, in many cases, clinical expertise in managing people with Polycystic Kidney Disease. The "Centers of Research" directory is a valuable resource for quickly identifying and locating leading medical authorities and medical institutions both within the United States and other countries who are considered to be at the forefront in clinical research and treatment of Polycystic Kidney Disease. You'd have to spend days - or even weeks - attempting to compile your own list of doctors and medical centers but, with the "Centers of Research" directory, the information is already right at your fingertips. All you have to do is act on the information by selecting and contacting the experts or medical institutions listed in the directory by state and country.
Organizations and Support Groups for Polycystic Kidney Disease - The Guidebook also includes a directory of organizations and support groups whose goal is to help people with Polycystic Kidney Disease by providing access to information, resources, and services. Many of these organizations can answer your specific questions, enable you to "network" with other patients, and provide guidance in areas such as financial, social, or medical-legal issues. This valuable directory of organizations and support groups includes complete contact information, including phone numbers and E-mail addresses.
Look Inside the Guidebook
The Guidebook is a Value-Added Proposition that Comes with a Risk-Free Satisfaction Guarantee so that...You have Nothing to Lose and Everything to Gain
Still not sure if you'll benefit from the Medifocus Guidebook on Polycystic Kidney Disease? Still not convinced that the information included in the Guidebook is worth the minimal cost? If that's the case, then please consider the following value-added proposition that comes standard with your purchase of the Guidebook:
Free Updates for One Year - Along with your initial purchase of the Guidebook, you also receive free updates for one-full year.
20% Discount - For a limited time, you can purchase the Medifocus Guidebook on Polycystic Kidney Disease at a special 20% discount off the regular list price. Your 20% discount will automatically be applied when you go to "Checkout".
Risk-Free Satisfaction Guarantee - Your purchase comes with our RISK-FREE satisfaction guarantee. If, for whatever reason, you are not totally satisfied with the content of your Guidebook, simply contact us within 30-days of your purchase for a prompt, full refund. We are so confident that you will be satisfied with your Guidebook that we offer this RISK-FREE satisfaction guarantee unconditionally - no questions and no hassles.
Order Your Copy of the Medifocus Guidebook on Polycystic Kidney Disease Today!
Updated: July 5, 2018169 Pages
This one of a kind Guidebook offers:
Order the Guidebook
The Medifocus Guidebook on Polycystic Kidney Disease is available in the following two convenient formats: Printed and Digital.
Discount Coupon Code
(automatically applied at checkout)
Coupon Expires: December 20, 2018
You can also receive a 20% discount when you order your Guidebook by phone.To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.
Discount Coupon Code forPhone Orders
What Our Customers Are Saying...
Privacy Policy
© 1996-2018 Medifocus.com, Inc. or its affiliates
Page Updated on:
July 5, 2018


text:
Chemotherapy for Retinoblastoma
Chemotherapy (chemo) is the use of anti-cancer drugs to treat retinoblastoma.
Ways of giving chemotherapy
Chemo can be given in different ways.
Systemic chemotherapy: In most cases, chemo drugs are injected into a vein (IV) or given by mouth. These drugs enter the bloodstream and reach throughout the body. This is known as systemic chemotherapy.
Periocular (subtenon) chemotherapy: For some advanced intraocular cancers, higher doses of chemo are needed inside the eye. Along with systemic chemotherapy, one of the drugs (carboplatin) may be injected in the tissues around the eye, where it slowly diffuses into the eyeball. This is called periocular or subtenon chemotherapy. These injections are done while the child is under anesthesia (asleep). This can cause redness and swelling around the eye.
Intra-arterial chemotherapy: A newer approach sometimes used instead of systemic chemotherapy is to inject chemo directly into the ophthalmic artery, the main artery that supplies blood to the eye. In this technique, a very thin catheter (a long, hollow, flexible tube) is inserted into a large artery on the inner thigh and slowly threaded through the blood vessels all the way up into the ophthalmic artery. (This is done with the child asleep under general anesthesia.) The chemo is then infused into the artery. The drug used most often is melphalan, but other drugs such as carboplatin and topotecan can also be used. This process may then be repeated every few weeks, depending on how much the tumor shrinks.
Because the chemo is put directly into the artery feeding the eye, doctors can use much smaller doses of chemo drugs (less than 10% of the doses used for systemic chemo). Therefore, there are fewer side effects from the chemo.
Early results with this technique in eyes with advanced tumors have been promising, generally with good tumor control and few side effects. In most cases it has allowed doctors to save an eye that otherwise would have needed to be removed.
Intravitreal chemotherapy: In this newer approach, chemotherapy is given directly into the vitreous humor, the jelly-like substance inside the eye. This approach is discussed in the section What's New in Retinoblastoma Research and Treatment?
Uses of chemotherapy
Chemotherapy may be used in different situations:
- Chemo can be used as the first treatment to shrink some tumors that have not spread outside the eye. This is called chemoreduction. These tumors can then be treated more effectively with focal therapies such as laser therapy, cryotherapy, thermotherapy, or brachytherapy.
- Systemic (IV) chemo may be given to children whose tumors don't seem to have spread beyond the eye, but might be likely to spread because of the tumor's size and/or location.
- Chemo is sometimes used when the eye has already been removed, but the tumor was found to extend into some areas in the eye that make it more likely to have spread. This type of treatment is called adjuvant chemotherapy.
- Systemic chemo is also used to treat children whose retinoblastoma has spread beyond the eye, a much more critical situation. If the cancer has spread to the brain, chemo may also be given directly into the cerebrospinal fluid that surrounds it (known as intrathecal chemotherapy). Tumors outside the eye may shrink for a time with standard doses of chemo, but they will usually start growing again. For this reason, doctors often prefer to give more intense chemo, usually along with a stem cell transplant. (See the section High-dose Chemotherapy and Stem Cell Transplant.)
Doctors give systemic chemo in cycles, with each period of treatment followed by a rest period to give the body time to recover. Each chemo cycle typically lasts for a few weeks, and the total length of treatment is often several months.
Some of the drugs used to treat children with retinoblastoma include:
- Carboplatin
- Cisplatin
- Vincristine
- Etoposide
- Cyclophosphamide
- Topotecan
- Doxorubicin
Most often, 2 or 3 drugs are given at the same time. A standard combination used to shrink intraocular retinoblastomas is carboplatin, vincristine, and etoposide, although for very small tumors, only carboplatin and vincristine may be enough. Other drugs might be used if these are not effective.
Possible side effects
Chemo drugs attack cells that are dividing quickly, which is why they work against cancer cells. But other cells in the body, such as those in the bone marrow (where new blood cells are made), the lining of the mouth and intestines, and the hair follicles, also divide quickly. These cells are also likely to be affected by chemo, which can lead to side effects.
Children tend to have less severe side effects from chemo and to recover from side effects more quickly than adults do. One benefit of this is that doctors can give them the high doses of chemo needed to kill the tumor.
The side effects of chemo depend on the type of drugs, the doses used, and how long they are given. Possible short-term side effects include:
- Hair loss
- Mouth sores
- Loss of appetite
- Nausea and vomiting
- Diarrhea or constipation
- Increased chance of infections (from having too few white blood cells)
- Easy bruising or bleeding (from having too few blood platelets)
- Fatigue (from having too few red blood cells)
Most of these side effects go away after treatment is finished. There are often ways to lessen these side effects. For example, drugs can be given to help prevent or reduce nausea and vomiting. Be sure to discuss any questions about side effects with your child's cancer care team, and let them know if your child has side effects so they can be managed.
Along with those listed above, certain chemo drugs can cause specific side effects. For example:
- Cisplatin and carboplatin can affect the kidneys. Giving the child plenty of fluids during treatment can help reduce this risk. These drugs can also cause hearing loss in young children, especially in babies younger than 6 months. Your child's doctor may check your child's hearing with tests during or after treatment. When carboplatin is injected directly into the tissues near the eye (periocular chemotherapy), it can cause redness and swelling in the area.
- Vincristine can damage nerves. Some children may feel tingling and numbness, particularly in their hands and feet.
- Some drugs, such as etoposide, doxorubicin, and cyclophosphamide, can increase the risk of developing a cancer of white blood cells known as acute myeloid leukemia (AML) later in life. Fortunately, this is not common.
- Doxorubicin can damage the heart. The risk of this happening goes up with the total amount of the drug given. Doctors try to limit this risk as much as possible by not giving more than the recommended doses and by checking the heart with an echocardiogram (an ultrasound of the heart) during treatment.
- Cyclophosphamide can damage the bladder, which can cause blood in the urine. This risk can be lowered by giving this drug along with plenty of fluids and with a drug called mesna, which helps protect the bladder.
For more information about chemotherapy, see the Chemotherapy section of our website.
Last Medical Review: March 12, 2015 Last Revised: March 12, 2015
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Treating Retinoblastoma
- Surgery (Enucleation) for Retinoblastoma
- Radiation Therapy for Retinoblastoma
- Laser Therapy (Photocoagulation) for Retinoblastoma
- Cryotherapy for Retinoblastoma
- Thermotherapy for Retinoblastoma
- Chemotherapy for Retinoblastoma
- High-Dose Chemotherapy and Stem Cell Transplant for Retinoblastoma
- Treatment of Retinoblastoma, Based on Extent of the Disease


text:
Autumn is finally here in the Northwest and that means it's a little "seasonal" outside when the sun goes down (an hour earlier now too). Not to worry, there's a host of great things going on inside to keep you warm every night this week. New Jersey natives Real Estate kick things off on MondayRead more…
Listen Live:
High Quality AAC+
Excellent for PC, Mac, iPhones/iPads, Android Devices, tablets, iTunes, Winamp, and VLC. High quality audio, low bandwidth
MP3 Stream
Best for computers running OSX or Windows with iTunes or the open source VideoLAN Player installed
KEXP AND THE UWKEXP is an
affiliate of the
University of Washington
iTunes and KEXPYou can now find KEXP under "Eclectic" in iTunes after the demise of the "Public" category, to better represent the diversity of our daytime variety shows and numerous specialty programs.
KEXP Suggests


text:
ozdavo wrote:nickl wrote:Dimma wrote:Buy in bulk, the price for a single item or 1000x is very different.
If it were as simple as that someone would be buying 1000 Ultegra Di2 groupsets and selling them on Ebay for $1200 and be making a killing.
if you have a spare million dollars sitting around, I doubt this is the best way to get a 20% return.
But when you think it though, this is pretty much what they are doing by selling the bike for $1995 - except in this case they need more than $1 million and the return is less than 20% (because of the other parts required to make the bike). Even in cases like supply on credit they must be sure they can get the parts for that price no matter how few orders they make.
Somehow they must be able to get smaller numbers (~100) of groupsets at this price ($800-$1000) - which makes me wonder how, and for what price exactly? Is it the kind of numbers it would make sense to put together a group-buy for?


text:
A Boudoir Brunch
Party Recap
My name is Shaundra and I started my business about two years ago. When I started it, my main focus was cakes. I have always loved planning and styling events, so I decided to take it to another level...I ABSOLUTELY LOVE IT!!!! A BOUDOIR BRUNCH was so much fun to plan and style! I contacted Danielle McCann about having a boudoir party and she was so excited, which made me even more excited about the brunch. While everyone was mingling and eaing, Danielle was shootig mini boudoir sessions...HOW AWESOME IS THAT?!?! I made the flower arrangements, catered, and styled the event. Danielle McCann is responsible for the amazing photography, and Hot Mama's Bakery created the gorgeous desserts. I was so ecstatic when I found the little dresser at a thrift store; I took it home, painted it, and LOVED the result. I hope that you enjoy!
Party Helpers
Danielle McCann Photography
Hot Mama's Bakery
Cake designer


text:
Thank you for visiting our past auction result archives. If you have an item identical (or similar) to this auction lot, please call, write or contact us to discuss. We will be able to help you.
Lot # 274 (of 1727) < Previous Lot | Next Lot >
1909-1911 T206 White Border PSA EX 5 Collection (91)
Starting Bid - $2,000, Sold For - $11,750
Collection of ninty-one T206 White Border tobacco cards, each graded and encapsulated EX 5 (except six EX+ 5.5) by PSA. All have Piedmont or Sweet Caporal advertising backs unless otherwise noted. The collection consists of the following: Alperman, Ames (port.), Arellanes, Ball (Clev.), Barger (EX+ 5.5), Barry (Phil.), Bell (hands above head), Bergen (bat), Bescher (port.), Bowerman, Brashear, Bridwell (no cap, Sovereign back), Bridwell (cap), Bush, Byrne, Cassidy, Chappelle, Congalton, Covaleski, Davis (Davis front), Dougherty (arm in air), Dygert, Freeman, Fromme, Geyer, Hannifan (Sovereign back), Hartsel, Hemphill, Herzog (NY), Hoffman (St. Louis), Hulswitt, Hunter (EX+ 5.5), Isbell, Jones (port.), Jordan (Bklyn, batting), Jordan (Bklyn, port.), Kleinow (catching), Konetchy (glove near ground), Krause (pitching), LaPorte, Lattimore, Livingstone, Lord, Maddox, McElveen, McLean (EX+ 5.5), Merkle (throwing), Merritt, Milan, Moran (Providence), Moran (Chicago), Mullen, Murray (port., EX+ 5.5), Myers (fielding), Niles, O'Hara (NY), Oldring (bat), Overall (hand face level), Paskert, Perring, Pfeffer, Phillippe, Purtell, Puttman, Quinn, Randall (EX+ 5.5), Reulbach (no glove, Polar Bear back), Rossman, Schaefer (Wash.), Schlei (batting), Schlei (catching), Schmidt (port.), Schmidt (throwing), Shipke, Slagle, Snodgrass (catching, Polar Bear back), Spade, Spencer, Stephens, Strang, Street (port.), Tannehill (Tannehill front), Thielman, Thomas, Unglaub, Warhop, White (Chicago, port.), White (Buffalo), Wilhelm (hands at chest), Willetts, and Wiltse (no cap, EX+ 5.5). This is a very impressive group that could serve as a substantial foundation for a high-quality T206 collection, or make a significant contribution to the completion of an extremely high quality set. The fact that all are in the identical grade, a grade which many believe offers one of the very best values for cards from the classic T206 series, makes this is a particularly noteworthy collection. This is an unusually large collection of quality T206 cards in the same grade to be offered as a collection. PSA EX 5 T206 commons list for $130 each in SMR. The total SMR value for the collection is $11,830. Total 91 cards. Reserve $2,000. Estimate $4,000/$6,000+. SOLD FOR $11,750
(Click the smaller thumbnails to the left and right (if any) to cycle through each photo in the gallery of images for this lot.)


text:
More insensitive remarks on CBS 'Big Brother' show
NEW YORK (AP) — A run of ethnically insensitive remarks has continued during filming for the CBS reality TV show "Big Brother," raising questions about whether the network should be doing more to police it.
One of the cast members on the program, which throws a group of people who don't know each other in a house together and films them to see how they get along, made remarks during the past week that could be seen as insulting to various ethnic groups.
On the 24-hour Internet feed of the house, Amanda Zuckerman, who's white, complained about a black cast member putting a headband on her greasy, "nappy-hair head." She referred to another black housemate as "the dark knight" and "the black mamba," mocked the accent of a Korean woman and referred to "Puerto Rican showers," leading to a debate about whether she's racist.
"I'm just joking," said Zuckerman, a 28-year-old real estate agent from Boynton Beach, Fla. "I've had sex with Puerto Rican guys before."
Earlier this summer, two other cast members were heard making anti-black comments.
CBS airs "Big Brother" on Wednesday, Thursday and Sunday during the summer, but Zuckerman's remarks haven't appeared on television.
CBS Corp. chief executive Leslie Moonves, whose wife, Julie Chen, hosts "Big Brother," said last week he finds some of the behavior on the show "absolutely appalling."
Public relations executive Joni Hudson-Reynolds, who writes a blog called ebonymompolitics, said young people watch the show and she believes CBS should be doing more to prevent the dissemination of offensive language.
"To just say 'This is reality television, and these are the kinds of things that are said in regular conversations' is not enough," Hudson-Reynolds said. "This is a controlled environment."
Hudson-Reynolds said she watches "Big Brother" with her teenage daughter, considering it a guilty pleasure. She doesn't go online to watch the day-to-day interactions. For people who don't follow it that closely, controversial comments are given greater circulation through compilations that are posted online.
CBS declined to comment further on the insensitive language. It's unclear whether there's a built-in delay on the Internet feed of what is going on in the household that would enable producers to cut off offensive talk.
Moonves, speaking to reporters last week, said he believed CBS was handling the situation appropriately.
"We did not comment on some of the racial things being said until it really affected what was going on in the household," he said.
Author Jennifer Pozner, who wrote "Reality Bites Back: The Troubling Truth About Guilty Pleasure TV," said she has a hard time believing show producers didn't get exactly what they wanted. A show like "Big Brother" is cast with people to increase the likelihood of table-flipping fights, drunken hook-ups and offensive language, she said.
"You know what — it's appalling, and you created it for that exact reason," Pozner said. "Why should we believe that you as a network did not get exactly what you wanted?"
"Big Brother," now in its 15th season, is averaging 7.1 million viewers per episode this season, up 9 percent over last year, the Nielsen ratings company said.
EDITOR'S NOTE — David Bauder can be reached at email@example.com or on Twitter @dbauder. His work can be found at http:bigstory.ap.org/content/david-bauder


text:
A gonnie is a person who is mentally challenged, they struggle to do many simple tasks. It can be hard to spot a gonnie as their exterior is normal, however, delve a little deeper and participate in a conversation with them and their true gonnieness is quickly revealed. Common signs of being a gonnie range from general slowness, being inept at hand eye coordination activities, poor spelling and grammar and an often vacant expression.
by Smeegul August 11, 2013
Australian Slang for a large Pebble usually
He threw a big Gonnie at me. There was a Gonnie down the drain pipe.
by Kezza1079 August 12, 2014


text:
Made from Scratch: Discovering the Pleasures of a Handmade Life : Starting off as a young, single woman with a desk job and a city apartment, Jenna Woginrich set out to build a more self-sufficient lifestyle by learning homesteading skills. She didn't own land or have much practical experience beyond a few forays into knitting and soap making, but she did have a strong desire to opt out of what she saw as a consumer-driven culture. After moving across the country to a rented farmhouse in northern Idaho, she learned to raise chickens, keep bees, and grow her own food. This is the story of her joyful, dramatic, and sometimes sorrowful journey toward self-reliance. Along the way, she learned that an abundance of enthusiasm and a willingness to experiment could make up for a lack of knowledge, and that reaching out to others for mentoring and guidance could help her reconnect with her community. In any setting -- urban, suburban, or rural -- with any level of experience, it's possible to take small steps toward self-reliance. Windowbox vegetable gardens, a batch of homemade strawberry jam, a handknit sweater, or a small flock of backyard chickens all satisfy the craving to homestead. It's not about having a rustic cabin on five acres, complete with a pickup truck and a barn full of livestock. For Woginrich, it's about being more receptive to learning the simple skills most of us have forgotten, and finding joy in the process.
|Biografía y Autobiografía


text:
Meetings / Hotel and Meeting Information
E29 Particle and Spray Characterization
We ask all attendees to preregister for this meeting. The registration information significantly assists us in preparations for the meeting.
The cut-off for preregistration is April 26, 2013.
Please click on the highlighted "Register Now" button above.
Best Western Oceanside Inn
Cut-Off Date: April 5, 2013 or when the ASTM block is full
There is a voluntary $40 Committee Activity Fee and a voluntary $100 ISO fee that can be paid during your online registration.
Any questions should be directed to:


text:
CRESTVIEW � Understanding health insurance options can be difficult � especially for residents who�ve never had coverage � but help is available for those who don�t know the difference between a premium and a pre-existing condition.
CRESTVIEW � Understanding health insurance options can be difficult � especially for residents who�ve never had coverage � but help is available for those who don�t know the difference between a premium and a pre-existing condition.
Barnes Insurance and Financial Services' Spencer Barnes and Drew Roberts, among others, are helping residents, at no charge, navigate the Health Insurance Marketplace website. Healthcare.gov is a result of the Affordable Care Act � commonly referred to as Obamacare � which President Barack Obama signed into law in 2010. Uninsured residents can visit the website and enroll for health insurance even with a pre-existing condition.
While Barnes and Roberts can�t solve widespread healthcare.gov glitches reported since the site�s launch, they have tried to separate fact from fiction.
For instance, numerous Americans have reported receiving calls from someone claiming to be from the federal government, saying they�re verifying personal information � including a bank account number � before an Affordable Care Act insurance card can be mailed, according to the Better Business Bureau. However, there are no Affordable Care Act insurance cards.
"There is a lot of conflicting information out there, so our goal is to educate people and let them know what is available to them," Roberts said.
Barnes and Roberts answered questions and advised residents on enrollment options Wednesday at the Crestview Area Chamber of Commerce office.
Deb Winter, a retired widow, said she appreciates the information. Winter, who has been unable to find health coverage due to preexisting conditions for the past five years, said she was skeptical when she first learned about the Affordable Care Act.
"I was thinking (the government) was going to be able to charge you whatever they wanted to, but after being here (Wednesday), I am excited about it."
A licensed Healthcare Exchange certified agent will offer the same assistance from 10 a.m. to 1 p.m. Oct. 14 and 9 a.m. to 1 p.m. Oct. 25 at the Crestview Public Library. More dates will be added if necessary.
Local insurance agent Eric Riggenbach will offer information on Medicare and coverage options 10-11 a.m. and 2-3 p.m. Nov. 6 at the library. Space is limited; call 862-8082 to reserve a seat.
WHAT:Health Insurance Marketplace information sessions
WHEN:10 a.m., noon, 2 p.m. and 4 p.m. Oct. 23
WHERE:Crestview Area Chamber of Commerce office, 1447 Commerce Drive
Contact News Bulletin Staff Writer Matthew Brown at 850-682-6524 or email@example.com. Follow him on Twitter @cnbMatthew.


text: Alexa, the high-end fashion broadsheet from the New York Post, is all about luxury shopping. So now we're expanding the brand beyond the catwalk. Welcome to Alexa Luxe Living, showcasing the most exclusive real estate for sale in and around the city. Alexa Luxe Living will take you inside the most elite properties in the New York area, while offering new design ideas and dish on how to buy and sell in the most competitive city in the world. If you're looking for a pricey pad — or just want to dream about one — this is the place to come . . . and luxe out.


text:
Boston Celtics Call Up Varnado From Skyforce
Coming into the 2012-2013 season, the Sioux Falls Skyforce had sent 42 players to the NBA. Make it 43 players as Jarvis Varnado will sign with the Boston Celtics.
For the second consecutive season, the Celtics extract a big man from the Skyforce after Greg Stiemsma played a full season with Boston last year. It is also marks the 21st season of 24 total that Sioux Falls has had a call-up from the NBA.
Varnado, a 6-foot-10 forward, averaged 14 points, 10 rebounds and 3.9 blocks per game in 10 appearances for the Sioux Falls Skyforce this season. He was originally was drafted out of Mississippi State in the second round (41st overall) in 2010 by the Miami Heat. He spent time in Israel and Italy as Miami retained his rights during his overseas stint. Varnado was in camp with Miami this fall, but was cut in the preseason and allocated to the Skyforce. Reports had Varnado working out in Boston on Sunday with a first opportunity to suit up for the Celtics on Christmas Day in Brooklyn against the Nets.
The GATORADE call-up for Varnado is the 6th of the season for the NBA Development League. This development is also a blow to rookie Fab Melo who was drafted by Boston in 2012. The Celtics assigned the 7-foot Melo to the Maine Red Claws of the D-League. Melo also recently set a league record for most blocked shots in a game Saturday against the Erie Bayhawks.


text:
N762, New August 2012
Editor's noteThe following abstract describes a publication that is only available for purchase. A link to ordering information is on this page.
Do you ever think about where your food comes from? How did it get to your grocery store, school or farmers market? Tomás the Tomato guides you on this journey from the farm to your table.
From the Farm to You DVD is intended for preschool through early elementary school age children. Created for the kindergarten farm to school program Food From the Farm, this 2012 Telly Award winning video can be used to supplement farm to school and school garden programs, or can form the basis of a classroom farm to table unit.
Order publications online at http://extension.missouri.edu/explore/shop/ or call toll-free 800-292-0969.


text:
Used Car Review
2010-2013 Chevrolet Equinox: Used Car Review
The 2010 to 2013 Chevrolet Equinox is a car-based compact crossover SUV that slots in between the smaller, retro HHR and the larger, almost full-size Traverse. The 5-passenger Equinox is one of General Motors' best-selling models, with an impressive list of standard equipment for the price. It offers a full complement of safety gear, including 10 airbags, OnStar crash notification and ABS, as well as traction and stability control. The second-generation Equinox, introduced for 2010, features a stylish interior, with ice-blue ambient lighting and upgraded materials. A segment-unique feature is its sliding rear seat, which can be moved fore and aft to apportion rear-passenger and cargo space as desired.
What We Like
Roomy back seat; good fuel economy with 2.4-liter 4-cylinder; attractive interior design and materials; nicely weighted steering
What We Don't
Hard seat cushions; harsh ride impacts; disappointing fuel economy with 3.0-liter V6; transmission shift hesitations and clunks
Fuel Economy & Engine Specs
The base engine is a surprisingly peppy 182-horsepower 2.4-liter 4-cylinder with a class-leading rating from the Environmental Protection Agency (EPA) of 22 miles per gallon city/32 mpg hwy on front-wheel-drive models and 20 mpg city/29 mpg hwy on all-wheel-drive versions. Optional on 2010-2012 LT and LTZ trims is a 264-hp 3.0-liter V6 that EPA rates at a less impressive 17 mpg city/24-25 mpg hwy for front-wheel-drive versions and 16-17 mpg city/22-24 highway for AWD models. Beginning in 2013, an optional 301-hp 3.6-liter V6 really wakes up performance while achieving the same fuel economy as the previous 3.0-liter V6 on LT and LTZ trims. Some 2011-2013 engines are flex-fuel-rated, meaning they can use either unleaded regular, E85 ethanol or a combination of the two fuels. Flex-fuel models have a yellow fuel cap. A 6-speed automatic transmission is used in all 2010-2013 Equinox models.
Notable Features & Options
The Equinox is available in base LS, mid-level LT and premium LTZ trims. Typical LS fare includes air conditioning, cruise control, tilt/telescope steering wheel, remote keyless entry, OnStar communication system, 6-speaker AM/FM/CD stereo, trip computer, rear wiper/washer, auto headlamps, power driver's seat, 17-inch alloy wheels, stability and traction control, ABS, split-folding rear seat, outside temp display and power doors, windows and mirrors.
Upgrading to LT nabs a standard compass, but more important is that it can be upgraded with popular options not available on the LS, including a more-powerful V6 engine, power lift gate, auto air conditioning, a power moonroof, navigation system, auto-dimming rearview mirror, an 8-speaker premium DVD audio system, fog lamps, a back-up camera, rear park assist system, leather seating, heated front seats and 18-in alloy wheels.
Moving up to LTZ typically scores standard heated leather seats with memory, steering wheel audio controls, auto air conditioning, a power lift gate, rear camera, an auto-dimming rearview mirror, fog lamps, a premium audio system and optional 19-in alloy wheels.
As long as there are young families with child safety seats, pets, sports gear and all the trappings thereof, compact and mid-size SUVs and crossovers will be in demand. The current-generation (2010 and newer) Equinox has a better reliability record than the previous version, and now that worries of GM's bankruptcy are over, expect resale values to hold up fairly well. To get a good idea of the Chevrolet Equinox's price range, we suggest the used car values at KBB.com. You can also search the AutoTrader Classifieds to see what models are for sale in your area.
The National Highway Traffic Safety Administration (NHTSA) has announced the following safety recalls for the 2010-2013 Chevrolet Equinox:
2010: Faulty climate-control module can cause defroster to be inoperative.
2011: Front seat belt buckles may fracture, separate and be unable to latch occupant.
2012: Incorrectly calibrated tire-pressure monitor may not warn driver of under-inflated tires.
Recall repairs are required by law even if the vehicle is out of warranty. Your dealer can check to see if the repairs were performed and, if not, will fix the car at no charge to you.
Safety Ratings & Warranties
NHTSA gave the 2010 Equinox five stars all around for crash protection. Tougher NHTSA tests beginning in 2011 rated the Equinox at four stars overall in front impacts, five stars overall for side impacts and four stars in rollover performance.
Insurance Institute for Highway Safety (IIHS) gave the 2010-2013 Equinox Good ratings for offset frontal, side and rear impacts.
General Motors covered the 2010-2013 Equinox with a 3-year/36,000-mile bumper-to-bumper warranty with roadside assistance, a 5-year/100,000-mile powertrain warranty and a 6-year/100,000-mile corrosion perforation warranty.
Chevrolet Certified Used SUVs must be five years old or less and have no more than 75,000 miles on the odometer. Each Equinox undergoes a 172-point inspection. Those that pass receive a 12-month/12,000-mile bumper-to-bumper warranty plus whatever remains on the transferable original 5-year/100,000-mile powertrain coverage. Also included is a new 2-year/24,000-mile maintenance plan and roadside assistance.
Behind the Wheel
Even though the 2010-2013 Equinox is bigger and heavier than most of its compact crossover competition, it's one of the better handling examples out there. It's stable on the highway, and the precise steering and lack of body lean in corners help it perform admirably on curvy roads. The ride, however, may be stiffer than some prefer, with bumps and ruts in the road intruding into the otherwise very quiet cabin. Most buyers will be satisfied with the performance and pleased with the fuel economy of the 182-horsepower 4-cylinder. The 264-hp 3.0-liter V6, optional on 2010-2012 models, lacks low-end torque and must be revved to make decent power, hurting fuel economy. A better choice on 2013 models is the optional 301-hp 3.6-liter V6, which makes the Equinox responsive in all driving situations with decent fuel efficiency.
Other Cars to Consider
The Honda CR-V is a top seller in the segment, and offers good fuel economy, excellent resale value and generous cargo space for its size. Yet it lacks an optional V6, and the rear seat is cumbersome to fold down.
Ford's Escape is another top seller among compact crossovers and offers a wide choice of powertrains, including a 4-cylinder V6 and gas-electric hybrid. The design, however, is dated, the cabin relatively noisy and hard plastic interior trim throughout.
AutoTrader's Advice
Look for an Equinox LT or LTZ with a nice level of options, such as heated seats, power driver's seat, a back-up camera and navigation. The premium-level seats have a more comfortable shape, and leather seat trim holds up better than cloth. This is one case in which sticking with the peppy, fuel-efficient, base 4-cylinder is a good choice. Unless you live in the mountains, front-wheel drive is all most folks will need. Go for a Chevrolet certified used car, when available, and make sure the climate-control, front seat belt and tire-pressure warning recalls have been done -- as well as transmission calibration updates.


text:
Home / Women's Apparel / Tonic
Women's Tonic Tennis Clothing & Apparel
Sort By: Most Popular | Newest | Price: High to Low | Price: Low to High | Name: A-Z | Name: Z-A
Select up to 4 products to compare, then click Compare Items Now: Compare Items Now
Based out of Vancouver, BC, Eco-conscious activewear brand Tonic wants you to sweat beautifully! Professional female athletes like Martina Hingis and Laura Siegemund wear Tonic's long lasting fabrics during hour long matches. Tonic want to improve not only the world with their environmentally-friendly production, but they want to improve your game as well with Dual Fit Light fabric with UV/UPF protection. Strength, durability, and performance help you gain the advantage as you play comfortably in clothes that you didn't imagine could feel so soft! Play, look, and sweat beautifully in the functional and supportive Tonic tennis apparel.


text:
Relax and unwind in Robe and enjoy the friendly service of our Onsite Managers – Robbie and Don for their top tips on things to do and see in Robe. They will also be more than happy to make a tour booking for you. You can be assured that your holiday at Robe is truly one to remember.
Amenities available at Harbour View Motel


text:
Protecting the individual's privacy on the Internet is crucial to the future of Internet-based business and the move toward a true Internet economy. itelligence has created this Privacy Statement to demonstrate our firm commitment to the individual's right to privacy. This policy outlines our personal information handling practices for this website.
This Privacy Statement covers this website and other sites that reference this Privacy Statement. Some itelligence entities, programs and/or sites may have their own, possibly different, privacy statements. We encourage you to read the privacy statements of each of the itelligence websites or program information you visit or review.
Our privacy practices reflect current global principles and standards on handling personal information. These principles include notice of data use, choice of data use, data access, data integrity, security, onward transfer, and enforcement/oversight. We abide by the privacy laws in the countries where we do business.
By using this Website, you consent to the collection and use of the information as described here. If we decide to make changes to this Privacy Statement, we will post the changes on this site so that you will always know what information we collect, and how we use it.
From time to time, as may be required by applicable law, we may also seek your explicit consent to process certain data and information collected on this website or volunteered by you.
To serve you better and understand your needs and interests, itelligence collects, exports, and uses personal information with adequate notice and consent, along with required filings with data protection authorities, when applicable.
When you visit our web site, we may record your IP address and use cookies and other Internet technologies (referred to below as Automated Tools and Embedded Web Links) to gather general information about our visitors and their interests. The technologies used and the information collected are described in more detail below.
We may further collect and process any information and data that you volunteer to us, e.g. when you register for events, subscribe to newsletters, participate in online surveys, discussion groups or forums, or when make purchases.
The information itelligence collects to understand your needs and interests helps itelligence deliver a consistent and personalized experience. We will use such information only as described in this Privacy Statement and/or in the way we specify at the time of collection. We will not subsequently change the way your personal data is used without your consent, as required by applicable law. Some of the ways we may use your personal data include, but are not limited to:
We use IP addresses to help diagnose problems, to administer our website, and to gather demographic information. We may also use IP addresses or other information, such as your itelligence.com user information you have shared on this website or at any earlier occasion or a campaign code, to determine which pages on our sites are being visited and topics that may be of interest so we can provide you with information about relevant products and services. Generally, itelligence will aggregate such data only in an anonymous way and will not tie it to a particular individual unless he or she has given consent. When you visit our site, we recognize only your domain name.
itelligence may also collect IP addresses (and other technical information such as browser type) during a Click-to-Chat or Click-to-Call sessions that you initiate. This information is collected when you connect to itelligence so that we may identify your session, deliver content based on the technical capabilities of your browser, and for quality control purposes. Your IP address will not be used to identify you unless you provide your prior consent.
itelligence will only gather information related to your visit to the itelligence site. We do not track or collect personal information from your visits to companies or entities outside the itelligence Group of companies.
This website uses Google Analytics, a web analytics service provided by Google, Inc. ("Google"). Google Analytics uses "cookies", which are text files placed on your computer, to help the website analyze how users use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of the website, compiling reports on website activity for website operators and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google's behalf. Google will not associate your IP address with any other data held by Google. You may refuse the use of cookies by selecting the appropriate settings on your browser, however please note that if you do this you may not be able to use the full functionality of this website.
In addition to the information you provide, itelligence may also collect information during your visit to an itelligence website through automated tools, which include Web beacons, cookies, embedded Web links, and other commonly used information-gathering tools. These tools collect certain standard information that your browser sends to our website such as your browser type and language, access times, and the address of the website from which you arrived at an itelligence website. Using these tools, itelligence is also able to confirm receipt of e-mails that the recipient consented to receive, and can track other information such as pages visited on the itelligence site and whether or not the recipient registers for an event offered by itelligence and certain other aggregate data that is not related to a particular individual.
Emails from itelligence often use links designed to lead you to a relevant area on the Web, after redirection through itelligence's servers. The redirection system allows itelligence to change the destination URL of these links, if necessary, and to determine the effectiveness of our marketing initiatives.
In emails, such links may also allow itelligence to determine if you have clicked on a link in the email, and the information about this interaction may be connected to your personal identity. If you do not want itelligence to collect information about the links you clicked, you can simply choose not to click on the links in an e-mail that itelligence sends you.
We use cookies to deliver personalized content, to save you having to re-enter your password repeatedly, to keep track of your shopping cart, and to tailor our information offerings to how you and others use the site.
If you choose to give us your e-mail address, we will communicate with you via e-mail. We do not share your e-mail address with others outside the itelligence Group of companies. You can choose not to receive any more e-mail at any time.
Depending on how your e-mail application is set up, information about you may be transmitted automatically when you send e-mail to itelligence.
If you choose to register for third-party services, we may need to send some information from your itelligence.com registration to the service provider, possibly including your e-mail address.
As a global company, itelligence operates a number of Web sites around the world. Any data and information that you volunteer or that is otherwise collected on one of our sites in any one country may be sent electronically to a server for one of these sites in another country. We safeguard your privacy interests around the world by ensuring that this itelligence site adheres to our data protection principles described in this statement.
Companies in the itelligence Group may use the information internationally in connection with processing your inquiries and orders, to help improve our products and services and for processing and storage.
We may also share such information with business partners, service vendors, authorized third-party agents or contractors in order to provide a requested service or transaction, including processing orders, processing credit card transactions, hosting websites, hosting event and seminar registration and providing customer support, or providing you with information on products and services that may be of interest to you.
We only provide these third parties with the minimum amount of personal data necessary to provide the services on our behalf, and the third parties are not permitted to use your personal data except for the limited purpose of completing the requested service or transaction.
We do not sell or rent your personal data to third parties for marketing purposes unless you have granted us permission to do so.
We may respond to subpoenas, court orders, or legal process by disclosing your personal data and other related information, if necessary. We also may choose to establish or exercise our legal rights or defend against legal claims.
Circumstances may arise where, whether for strategic or other business reasons, itelligence decides to sell, buy, merge or otherwise reorganize businesses in some countries. Such a transaction may involve, in accordance with applicable law, the disclosure of personal information to prospective or actual purchasers, or the receipt of it from sellers. It is itelligence's practice to seek appropriate protection for information in these types of transactions.
We may collect and possibly share personal data and any other additional information available to us in order to investigate, prevent, or take action regarding illegal activities, suspected fraud, situations involving potential threats to the physical safety of any person, violations of itelligence's terms of use, or as otherwise required by law.
While visiting itelligence's website you may be directed to content or functionality that is hosted by a third-party supplier, not on itelligence.com. Most often, this is done to host special events, such as contests or seminars. When information is collected on behalf of itelligence exclusively, the appropriate itelligence entity's Privacy Statement will be referenced on the site and will govern how information is used. For other, non-itelligence sites, the site's owner's privacy policy will be referenced. It is itelligence's practice to require such suppliers and business partners to handle information in a manner consistent with itelligence's Privacy Statement.
itelligence is committed to protecting the personal data you share with us. itelligence uses a combination of industry-standard security technologies, procedures, and organizational measures to help protect your personal data from unauthorized access, use or disclosure. itelligence supports online security using secure server technology because we want your data to be safe. There are state-of-the-art security arrangements and facilities on itelligence sites to prevent abuse.
We bind our employees to observe your privacy and confidentiality rights.
This site may contain links to other sites. itelligence is not responsible for the privacy practices or the content of other websites outside the itelligence Group of companies.
We communicate with users who subscribe to our services on a regular basis via email, and we may also communicate by phone to resolve customer complaints or investigate suspicious transactions. We may use your email address to confirm your opening of an account, to send you notice of payments, to send you information about changes to our products and services, and to send notices and other disclosures as required by law. Generally, users cannot opt out of these communications, but they will be primarily informational in nature rather than promotional.
itelligence provides you the opportunity to exercise an opt-out choice if you do not want to receive other types of communication from us such as emails or updates from us regarding new services and products offered on this website or if you do not want us to share your personal information with third parties. The opt-out choice may be exercised by unsubscribing at firstname.lastname@example.com
itelligence will not retain your personal data longer than is necessary to fulfill the purposes for which it was collected or as required by applicable laws or regulations.
itelligence does not knowingly collect Personal Data from children under the age of 13. If we learn that we have collected Personal Data on a child under the age of 13, we will delete that data from our systems.
Have questions? Please contact us.


text:
Let's take a journey through the air passageways of the lungs. Within the lungs, you can see a network of tubes called the bronchial tree, through which air enters and leaves your body.
Upon inhalation, the air you breathe in passes through the trachea (windpipe) and follows the network of bronchial tubes into each lung. The winding passageways branch into smaller and smaller sections, which end at tiny air sacs called alveoli. In each alveolus, the oxygen you inhale is exchanged for the carbon dioxide released from the cells in your body. The carbon dioxide is expelled in the reverse direction during exhalation.


text:
works from: Mark Warren Jacques (Portland, OR), Maya Hayuk, Cody Cochrane (Toronto), Ellie Curtis (London), Amy E Mayfield (Chicago, IL), Aiyanna Udeson, Kate Lasher, Jason Vivona, Jessica Trippe, Joe Neff, Ruth Swanson, Llewellyn Bryan Dawson, Mara Baldwin, Jesse Nicholson, under thecobblestones, Clanchatti (Toronto), and Jeremy Bradley Earl (from Woods and Woodsist)
@Space Gallery tonight (Saturday ~7-12am ~details)
"Ease Youself and Glide" is derived from the name of a Parsley Sound song that I love. The phrase just got stuck in my head and became a mantra of sorts. I've created a summer show full of vibrant, beautiful, art pieces composed of prints, paintings, collage, drawings and photos. I chose artists that I'm drawn to and it's all come together to form a really eclectic, but cohesive, show. Right now I'm just trying to live, not forcing things to be how I think they should be but just relaxing and letting them come together and be how they are. This summer is all about getting mellow and not allowing the hard parts of life to carry too much weight. Gliding and having faith were all landing where were meant to, strongly, softly, and with big, fun bang. -Ruth Swanson, curator
|< Prev
|Next >


text:
A person with persistent, possibly permanent, sexual incapacity -- inability to achieve either erection or orgasm, or drastically reduced libido -- due to the side effects of SSRI antidepressants.
Uh, hon, you might think twice about going with that SSRI victim -- if you want a sex life, that is.
by DancingKali May 04, 2011
buy the domain for your foodie vlog


text:
FIVE WILLOWS LITERARY REVIEW This is an online literary review of the Chrysanthemum Literary Society for selected works that fit the spirit of Mr. Five Willows.Please see our "Current Issue" for guidance. Send your work via email to email@example.com both in the body of the email and as an attached Word file. Response time is immediate to 2 weeks. Thank you. All donations are tax-deductible.
Tuesday, April 11, 2017
Marjorie Sadin ----------- Two Poems
Subscribe to: Post Comments (Atom)
The Disembodied Hand by Koon Woon
The Disembodied Hand The hand that moves across the sterile hours in a ward for the insane…that wanders over the bare breasts of mad w...
See Liam Roche's poems under Five Willows Poetry http://fivewillowspoetry.blogspot.com


text:
I have some amazing people in my life.
Two months ago, my husband and I moved apartments
and started attending a different church congregation
Although they hardly know me, they decided to throw me a baby shower.
I know. I have amazing people in my life.
I couldn't get over how cute everything turned out!
Did you look at those cupcakes!?
cute, right!
And did you notice all of the fun "shower" decor?
Seriously amazing
I had a blast, and felt lucky to get to know so many awesomely crafty women!


text:
Samuel Heath products are available from selected bathroom showrooms and department stores
Classic wall mounted shower arm for shower heads. Made in England from the finest materials with a combination of the latest technology and hand craftsmanship. Employing a high quality plating process to ensure a flawless finish
Classic 8 inch skirted shower headCode: V908
Classic 4 inch skirted shower headCode: V904
Classic 12 inch skirted shower headCode: V912
Contemporary shower headCode: V177
Contemporary shower headCode: V163
Download technical product information. Professional assets may require you to register or login